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Study Objectives: To assess the effects of an Acute Pain Service (APS) inception on
postoperative pain management in a general teaching hospital using pain indicators as
performance measures.
Design: Open, prospective, nonrandomized, observational study.
Setting: Postanesthesia Care Unit, surgical wards of University Hospital Center of
Charleroi.
Patients: 1304 patients in the pre-APS inception phase and 671 patients after its
implemention who have undergone various types of surgery (orthopedics, gynecology,
urology, neurosurgery, stomatology, ear, nose, and throat, ophthalmic, abdominal,
vascular-thoracic, plastic, and maxillofacial).
Interventions: An APS, nurse-based, anesthesiologist-supervised model was devised,
based on the concept that postoperative pain relief can be greatly improved by providing
in-service training for surgical nursing staff and optimal use of systemic analgesics.
Measurements and Main Results: Postoperative pain was assessed using a visual
analog scale (VAS) every 4 hours for 72 hours in the two phases. Analgesic consumption
was registered at the same time. Time-related VAS scores were summarized using several
pain indicators. There was an overall improvement in the pain scores after APS inception.
The differences were most pronounced, around 50%, in patients undergoing vascular,
maxillofacial, gynecologic, and urologic surgeries, and stomatology. Regular administra-
tion of paracetamol and nonsteroidal antiinflammatory drugs decreased morphine
consumption in the second phase.
Conclusion: This study validates the benefits of a formal APS, using continuous
monitoring of rest pain intensity and analgesic consumption in the postoperative period.
Results not only support previous research findings but also offer outcome-based tools to
evaluate current practices as compared with desired outcomes. © 1999 by Elsevier
Science Inc.
Keywords: Analgesics, opioid; morphine; pain, postoperative; pain service,
acute: audit; visual analog scale.
Introduction
In September 1990, in their “Report of the Working Party on Pain After
Surgery,” The Royal College of Surgeons of England and the College of
Journal of Clinical Anesthesia 11:583–589, 1999
© 1999 Elsevier Science Inc. All rights reserved. 0952-8180/99/$–see front matter
655 Avenue of the Americas, New York, NY 10010 PII S0952-8180(99)00101-4
Anesthetists suggested that all major hospitals should
establish an Acute Pain Service (APS).1 Since then, the
problem of acute pain has been addressed by a number of
professional bodies, including the Agency for Health Care
Policy and Research (AHCPR) in 1992, the International
Association for the Study of Pain (IASP) in 1992, the
American Pain Society, and the American Society of
Anesthesiologists (ASA) in 1995.2–5
First described by Ready et al.6 in 1988, a number of
publications on the establishment of APSs have appeared
during the last few years.6–12 Two main types of APS
models have been proposed: anesthesiologist-based or
nurse-based. Anesthesiologist-based APS organizations
usually provide “high-tech” pain management services.6
This situation is not surprising, as anesthesiologists clearly
have special expertise in the field of advanced analgesic
techniques, such as patient-controlled or epidural analge-
sia. Although implementation of an anesthesiologist-based
APS has had considerable impact on pain management in
surgical wards, only a small percentage of patients receive
the benefits of the Service.12
Others have proposed a complete approach to the
management of postoperative pain, e.g., the nurse-based
anesthesiologist-supervised APS model described by Rawal
and Berggren12 in 1994, which is expected to benefit to all
surgical patients. As these authors stated, the solution to
the problem of inadequate postoperative pain relief lies
not so much in the development of new techniques but
rather in the establishment of a formal organization inside
the hospital.
In Europe, a survey of APS availability in 105 hospitals
from 17 countries showed that 50% of anesthesiologists
were dissatisfied with postoperative pain management on
surgical wards. Only 34% of hospitals had an organized
APS, and few hospitals used quality assurance measures
such as repeated pain assessment and documentation.13
The present study was intended to describe the effec-
tiveness of a nurse-based APS inception on postoperative
pain management in a general teaching hospital. We also
attempt to define criteria, including pain indicators and
analgesic consumption, which might be considered as
performance measures.
Materials and Methods
The study was conducted in a general university teaching
hospital of 1,005 beds, 240 of which are located on surgical
wards. University Hospital Center of Charleroi Local Eth-
ics Committee approval was obtained prior to the start of
the study, and verbal informed consent was given by all
patients who agreed to participate.
Phase I: The Pre-APS Period
An initial survey of postoperative pain management qual-
ity was performed over a 6-month period (January to June
1997), including all surgical inpatients, undergoing vari-
ous procedures [orthopedics, gynecology, urology, neuro-
surgery, stomatology, ear, nose, and throat (ENT), oph-
thalmic, abdominal, vascular-thoracic, plastic, and
maxillofacial surgeries]. Patients were included in the
study if they were more than 15 years old, were able to
read and understand French, had normal mental health,
and were hospitalized for elective surgery. Inclusion was
prospective and consecutive. At the time of the preopera-
tive visit, patients were familiarized with a 10-cm visual
analog scale (VAS) device (0 5 no pain at all, 10 5 worst
imaginable pain). Exclusion criteria involved patients un-
able to understand or realize the VAS test, patients trans-
ferred directly to an intensive care unit (ICU) bypassing
the postanesthesia care unit (PACU), and patients with
emergency or ambulatory procedures. Patients receiving
postoperative epidural analgesia were observed in the ICU
and excluded from the present survey.
The study focused on postoperative VAS pain scores of
patients treated with systemic analgesics administered
intravenously (IV), including patient-controlled analgesia
(PCA), intramuscular (IM) and oral routes, prescribed by
anesthesiologists, and administered by ward nurses. No
special instructions were given to the attending anesthesi-
ologist regarding anesthesia and postoperative analgesia
regimens.
On arrival in the PACU, patients were asked to rate
their pain experience on the VAS device, which was held
by the nurse. This process was repeated every 2 hours for
the first 4 hours. When the patient moved to the general
surgical ward, it was continued every 4 hours for 72 hours.
Only rest pain was assessed, defined as the pain experi-
enced by the patient while lying in bed. The pain thresh-
old was set at 3 cm on the VAS scale.12 Pain was not
assessed while the patient was asleep. Participation of
nurses was voluntary at first, based on interest and/or
involvement in the pain management process, but it
rapidly was extended to all surgical ward staff as a new
nursing activity.
All analgesic medications given for pain control were
carefully recorded for each patient on a specially designed
documentation form. This included the type, dose, and
frequency of injected opioid ordered by the attending
anesthesiologist. All results were later expressed in terms
of mg morphine equivalents.14 The administration of
peripherally acting analgesics, such as paracetamol and
nonsteroidal antiinflammatory drugs (NSAIDs), was regis-
tered. Patient records were reviewed in detail by the study
investigators.
The demographic and clinical variables used in this
study included age, gender, type of surgery, type of
anesthesia (regional or local/regional), VAS scores, mor-
phine consumption (mg), paracetamol consumption (g),
and NSAID administration (no/yes) during the 72-hour
postoperative period.
Phase II: The APS Inception Period
An APS nurse-based anesthesiologist-supervised model was
set up in October 1997. This model, developed by Rawal
and Berggren,12 is based on the concept that postopera-
tive pain relief can be greatly improved by providing
in-service training for surgical nursing staff, and optimal
use of systemic paracetamol, NSAIDs, and opioids.12 Reg-
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ular assessment of pain intensity by VAS every 4 hours and
recording of treatment efficacy on a bedside vital-sign
chart are the cornerstones of this model. The organization
is based on an acute pain nurse (APN) and pain represen-
tatives, namely, acute pain and section anesthesiologists,
ward ,surgeons and day or night nurses. The APN makes
daily rounds on all surgical departments and registers
problems with analgesia, side effects of treatments, and
patient satisfaction. The satisfaction of patient is assessed
using a four-point verbal descriptive scale as follows: very
dissatisfied, dissatisfied, satisfied, and very satisfied. The
pain representatives day and night nurses are responsible
for implementation of pain management guidelines and
monitoring routines on his or her surgical ward, and the
pain representative surgeon is in charge of pain manage-
ment for his or her surgical specialty. They participate at
quarterly “pain representative” meetings. Pain manage-
ment guidelines were established by the department of
anesthesia and agreed on by surgeons, with an emphasis
on multimodal pain therapy using a combination of
paracetamol, NSAIDS, and opioid analgesics.2,15,16 Anal-
gesia option includes routine 6-hourly use of paracetamol
IV or orally, and subcutaneous morphine injection if VAS
is greater than 3 cm. If the patient reports inadequate pain
relief within 45 minutes after injection (VAS . 3), he or
she is administered a rescue injection that corresponds to
50% of the initial dose of morphine. If pain control is still
unsatisfactory, the anesthesiologist on call is contacted.
NSAIDs are given at fixed dosage, depending on the type
of surgical procedure. Intensive in-service training of
nursing and medical staff was undertaken. Nursing guide-
lines establishing the assessment of pain every 4 hours and
reassessment 45 minutes after rescue medication were
defined. The 4-hourly interval was chosen in consideration
of the 3- to 4-hour duration of morphine action and our
nursing care schedule.2 Information pamphlets are given
to all patients, whereby they are informed preoperatively
that every effort would be made to maintain their VAS
below the previously defined threshold of 3 cm. Patient-
controlled analgesia prescription is restricted to selected
patients suffering severe pain or for long-duration treat-
ment. All these pain management procedures were in-
stalled and implemented simultaneously following the
Rawal and Berggren12 APS description.
Phase III: The Post-APS Period
Four months after the APS inception, a new survey was
conducted during a 3-month period (February to April
1998) on consecutive surgical inpatients, using the same
methodology as that described for Phase I.
Statistical Analysis
Results were expressed as means 6 SD for quantitative
variables and as frequencies for categorical findings. Time-
related VAS measurements were summarized using a
series of pain indicators as described elsewhere: AUC: Area
under the VAS-time curve (cm 3 hr); Mean VAS (cm);
VASmax: peak of VAS (cm); Tmax: time of VASmax (h);
PVAS . 3: the persistence of VAS over 3 cm, i.e., the time
period during which VAS was above the critical threshold
(h); Pdur: pain duration, i.e., the time period during
which the patient reported pain (VAS . 0) during the 72
hours (h).17 The comparison of mean values (age, pain
indicators, and paracetamol and morphine consumption)
observed in the pre-APS and post-APS periods was done by
the Student t-test, whereas proportions (gender, NSAID
use) were compared by the classic x2 test. To assess the
efficacy of the APS on pain indicators and drug consump-
tion while adjusting for age, gender, type of anesthesia,
and surgical procedure, a general linear model (GLM)
was applied to the data. The number of patients included
in the post-APS study period was based on a power
calculation assuming a 20% reduction in pain indicators,
with a 5 0.05 and b 5 0.20. All statistical calculations were
carried out using the SAS package (version 6.12; SAS
Institute, Cary, NC) and always using all data available.
Results were considered to be significant at the 5% critical
level (p , 0.05).
Results
A total of 1,304 patients with complete file was included in
the pre-APS study period, and 671 patients were retained
for the post-APS phase. Patients of the two groups were
homogenous with respect to age and gender (Table 1).
Mean age was 48.4 6 17.9 years in the evaluation study and
47.7 6 17.4 years in the reevaluation study (p 5 0.39). In
the pre-APS phase, there were 704 (54%) women and 600
Table 1. Demographic Data and Distribution of Patients Ac-






(n 5 671) p-Value
Age (yrs) 48.4 6 17.9 47.7 6 17.4 0.394
Gender
Female 704 (54%) 354 (53%) 0.603
Male 600 (46%) 317 (47%)
Type of surgery
Orthopedic 407 (31%) 141 (21%)* ,0.001
Neurosurgery 140 (11%) 54 (8.1%)
Vascular 37 (2.8%) 32 (4.8%)
Ophthalmology 42 (3.2%) 8 (1.2%)*
Maxillofacial 55 (4.2%) 41 (6.1%)
Gynecologic 84 (6.4%) 69 (10%)*
Urologic 68 (5.2%) 58 (8.6%)*
Plastic 54 (4.1%) 32 (4.8%)
Abdominal 339 (26%) 184 (27%)
Stomatology 22 (1.7%) 23 (3.4%)*
ENT 56 (4.3%) 29 (4.3%)
Type of anesthesia
GA 990 (76%) 480 (72%) 0.034
LRA 314 (24%) 191 (28%)
APS 5 Acute Pain Service; ENT 5 ear, nose, and throat; GA 5
general anesthesia; LRA 5 local/regional anesthesia.
*Statistically significant at p , 0.05.
Acute pain service: Bardiau et al.
585J. Clin. Anesth., vol. 11, November 1999
(46%) men. In the post-APS phase, 355 (53%) women and
316 (47%) male patients were involved (p 5 0.60).
The distribution of patients according to type of sur-
gery differed significantly between the two phases (p ,
0.001). Multiple comparisons revealed that this fact was
due mainly to a decrease in the proportion of orthopedic
patients (31% in the pre-APS phase vs. 21% in the
post-APS phase) and to a lesser extent of ophthalmologic
patients (3.2% vs. 1.2%), compensated by a relative in-
crease in the proportion of patients undergoing gyneco-
logic (6.4% vs. 10%), urologic (5.2% vs. 8.6%), and
stomatology (1.7% vs. 3.4%) interventions.
As for the type of anesthesia, we found a significantly
higher proportion of patients operated given local/re-
gional anesthesia in the post-APS phase (28% vs. 24% in
the pre-APS phase; p 5 0.034). As seen from Table 2, this
increase essentially occurred in gynecologic and plastic
surgery interventions.
The values of pain indicators observed in the pre-APS
and post-APS periods are listed in Table 3. A highly
significant reduction (p , 0.0001) of all pain indicators
was observed after APS inception, except for the time of
maximum VAS, which remained unchanged. The APS
effect on pain indicators remained highly significant, even
when adjusting for age, gender, surgical procedure, and
type of anesthesia (p , 0.0001). As seen in Table 4, there
was a major improvement (.50%) in the pain scores
observed following APS inception in patients undergoing
vascular, maxillofacial, gynecologic, and urologic surger-
ies, and stomatology. In the post-APS phase, pain intensity
was the highest in orthopedics and neurosurgery patients.
In the latter group, most of the patients underwent disc
surgery. In ophthalmology, ENT, and plastic surgeries,
pain scores did not significantly improve in the post-APS
phase.
Analgesic consumptions in the pre-APS and post-APS
phases are listed in Table 5. Paracetamol and NSAID use
increased markedly in the post-APS as compared with the
pre-APS phase (paracetamol: 5.3 6 4.0 g vs. 9.7 6 6.2 g;
p , 0.0001; NSAIDs: 20% vs. 64% of patients, p , 0.0001).
At the same time, morphine administration decreased
significantly from 14 6 23 mg to 11 6 23 mg (p 5 0.038).
When adjusting for age, gender, surgical procedure, and
type of anesthesia, results remained highly significant (p ,
0.0001) for paracetamol and NSAIDs but became nonsig-
nificant for morphine (p 5 0.51). Table 6 lists analgesic
consumption in the various surgical groups. In the post-
APS phase, paracetamol and NSAIDs were given more
regularly to patients of all but one (ophthalmology)
surgical department. However, morphine consumption
increased in neurosurgery (from 15 6 26 mg to 28 6 36
mg; p , 0.001) but significantly decreased in vascular,
gynecologic, urologic, and abdominal surgeries. The
range of morphine consumption was extremely variable,
from 0 to 177 mg in the pre-APS period and 0 to 240 mg
in the post-APS period. No life-threatening respiratory
events associated with opioid administration were re-
ported during the study period.
Patient-controlled analgesia prescription did not in-
crease after APS inception: 20 patients (1.5%) received
PCA in the pre-APS and 10 in the post-APS (1.4%) phases
(NS).
Discussion
This study demonstrates the improvement in pain man-
agement quality after introducing a nurse-based, anesthe-
siologist-supervised, APS model into a general teaching
hospital. All surgical subpopulations benefited from the
new organization of pain management. These results are
in agreement with previous surveys.8–10,12,18,19 But, in our
survey, the improvement was more pronounced in some
surgical specialties, such as vascular, maxillofacial, gyneco-
logic, and urologic surgeries, and stomatology, than after
painless procedures, such as ophthalmology, ENT, and
plastic surgeries.20
Rest pain intensity was measured using five endpoints
Table 2. Number (percent) of Patients According to Type of





GA LRA GA LRA
Orthopedic 246 (60.4) 161 (39.6) 74 (52.5) 67 (47.5)
Neurosurgery 129 (92.1) 11 (7.9) 51 (94.4) 3 (5.6)
Vascular 15 (40.5) 22 (59.5) 13 (40.6) 19 (59.4)
Ophthalmology 42 (100) 0 8 (100) 0
Maxillofacial 52 (94.5) 3 (5.5) 41 (100) 0
Gynecologic 78 (92.9) 6 (7.1) 54 (78.3) 15 (21.7)*
Urologic 33 (48.5) 35 (51.5) 25 (43.1) 33 (56.9)
Plastic 54 (100) 0 28 (87.5) 4 (12.5)*
Abdominal 263 (77.6) 76 (22.4) 137 (74.5) 47 (25.5)
Stomatology 22 (100) 0 20 (87.0) 3 (13.0)
ENT 56 (100) 0 29 (100) 0
Total 990 (75.9) 314 (24.1) 480 (71.5) 191 (28.5)
APS 5 Acute Pain Service; GA 5 general anesthesia; LRA 5
local/regional anesthesia; ENT 5 ear, nose, and throat.
*Proportions of LRA patients in pre-APS and post-APS significantly
different (p , 0.05).






(n 5 671) p Value*
AUC (cm 3 hr) 99 6 94 59 6 69 ,0.0001
Mean VAS (cm) 1.5 6 1.4 1.0 6 1.1 ,0.0001
VASmax (cm) 4.8 6 2.6 3.9 6 2.5 ,0.0001
Tmax (hr) 8.2 6 12 8.2 6 13 0.9812
PVAS . 3 (hr) 12 6 16 6.1 6 11 ,0.0001
Pain duration (hr) 39 6 25 28 6 22 ,0.0001
APS 5 Acute Pain Service; VAS 5 visual analog scale; PVAS 5
persistence of VAS over 3 cm.
*p-Values remained significant when adjusting for age, gender,
surgical procedure, and type of anesthesia.
Original Contributions
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during the 72-hour study period: AUC, mean VAS,
VASmax, PVAS . 3, and Pdur. These items, which may be
considered as outcome measurements, were sensitive
enough, particularly AUC, mean VAS, PVAS . 3, and
Pdur, to demonstrate the predictable reduction of pain in
the post-APS phase. They appear clinically relevant to pain
management practices, and they are both reliable and
valid. In conducting the present study, a database was
instituted, which can serve as a source of information for
further statistical analysis and research, and it ensures that
trends of efficacy or complications can be addressed. The
five endpoints described in the present study may be used
to monitor quality of pain relief, providing the hospital
with clear information on which areas of pain manage-
ment need improvement. These outcome data also could
be used as report cards.21 Designing tools to guide physi-
cians and nurses to initiate and modify analgesic treat-
ments expertly is an immediate challenge for implement-
ing a quality assurance project.
Nurse-based APS have been previously described.
Gould et al.9 reported improvement in postoperative an-
algesia after introduction of such services. The general
organization of our APS has been modeled on the APS
described by Rawal and Berggren12 in 1994. The Swedish
model has been introduced in our hospital without any
modification. Briefly, pain management is based on regu-
lar recording of patient’s pain intensity using VAS, regular
administration of paracetamol and NSAIDs, and optimal
use of systemic opioids protocols. Pain management
guidelines, standard order, and monitoring routines have
been developed for each surgical specialty in cooperation
with surgeons and section anesthesiologists. An acute pain
anesthesiologist and a nurse coordinate pain management
and chair the quarterly APS meetings of section anesthe-
siologists, surgeons, and pain representative ward nurses.
The usual topics of discussion at these meetings are
practical pain problems, protocol modifications, sugges-
tions for improvement of services, and introduction of
newer techniques. Adoption of a multidisciplinary team
approach leads to marked improvement in postoperative
pain relief. The acute pain anesthesiologist has the overall
responsibility for the APS, including monitoring routines
and teaching programs for all staff. Another advantage of
this model is the low cost, estimated at $3 to $4 U.S. per
patient.12
Our data are in line with previous studies or suggestions
from different professional groups, such as the American
Pain Society, ASA, and AHCPR, showing that a multidisci-
plinary approach leads to marked improvement in post-
operative pain relief.2,4–10
One of the major goals of the study was implementa-
tion of clinical nursing standards for pain management.
Standardization and stabilization of nursing practice re-
lated to pain management is an essential aspect of improv-
ing patient clinical outcomes. This finding is in agreement
with the literature, which advocates the necessity of devel-
oping institutional programs for improving pain manage-
ment.22,23
Morphine is still the treatment of reference for the
relief of acute postoperative pain.24 The most common
method of opioid use is IM or subcutaneous administra-
tion on an as-needed basis. Nevertheless, the inadequacies
of this method of pain management have long been
recognized.25–27 In our protocol, morphine is adminis-
Table 4. Comparison of Three Major Pain Indicators in the Pre-APS and Post-APS Phases According to Type of Surgery
Type of Surgery
AUC (cm 3 h) PVAS > 3 (h) Pain duration (h)
Pre-APS Post-APS Pre-APS Post-APS Pre-APS Post-APS
Orthopedic 112 6 101 86 6 94 15 6 18 9.8 6 15 40 6 26 33 6 23
Neurosurgery 136 6 123 98 6 80 17 6 21 12 6 14* 46 6 24 38 6 23
Vascular 62 6 67 22 6 31 6.4 6 12 2.1 6 4.5* 27 6 19 13 6 15
Ophthalmology 19 6 18 27 6 30* 0.93 6 1.7 2.0 6 5.3* 13 6 10 13 6 13*
Maxillofacial 92 6 83 55 6 47 11 6 15 5.0 6 7.2 39 6 26 28 6 17
Gynecologic 105 6 97 52 6 67 14 6 16 5.4 6 10 39 6 27 25 6 25
Urologic 77 6 91 33 6 47 9.7 6 15 3.1 6 7.7 32 6 29 18 6 18
Plastic 87 6 69 57 6 73* 9.3 6 13 6.1 6 14* 41 6 22 27 6 20
Abdominal 102 6 79 57 6 54 11 6 14 5.1 6 8.8 45 6 23 30 6 20
Stomatology 34 6 24 17 6 20 4.2 6 5.2 0.8 6 1.8 16 6 6 13 6 14*
ENT 40 6 45 34 6 40* 2.8 6 5.8 2.2 6 4.3* 23 6 18 18 6 19*
APS 5 Acute Pain Service; AUC 5 area under the curve; PVAS 5 persistence of visual analog scale over 3 cm; ENT 5 ear, nose, and throat surgery.
*NS.
Table 5. Comparison of Analgesic Consumption in Pre-APS and
Post-APS Phases
Drug Pre-APS Post-APS p-Value
Paracetamol (g) 5.3 6 4.0 9.7 6 6.2 ,0.0001
NSAIDs (%) 20% 64% ,0.0001
Morphine (mg) 14 6 23 11 6 23 0.0385
APS 5 Acute Pain Service; NSAIDs 5 nonsteroidal antiinflammatory
drugs.
*p-Values remained significant when adjusting for age, gender,
surgical procedure, and type of anesthesia, except for morphine (p 5
0.51).
Acute pain service: Bardiau et al.
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tered if the level of pain reached 3 on the VAS. With
attentive nursing care, conventional subcutaneous opioid
therapy appears as effective as PCA.12,28 As Choinie`re et
al.28 recently stated, most studies establishing the analgesic
superiority of PCA compare PCA with on-demand IM
dosing, and not with a regularly scheduled mode of
administration of the drug. These authors also showed
that PCA is more costly and does not appear to have
clinical advantages in terms of patient satisfaction, the
side-effect profile, or the rate of postoperative recovery
after hysterectomy.28 Sophisticated analgesia techniques
such as PCA is neither necessary nor realistic for all
surgical patients. Equipment problems are an additional
concern. In our hospital, PCA is targeted specifically to
patients expected to do poorly with regularly administered
subcutaneous injections (e.g., severe pain or long dura-
tion of treatment) representing 1.4% of patients in the
post-APS phase.29,30 Perhaps PCA is better suited to other
patient categories or surgical procedures.
Paracetamol and NSAIDs given by the clock and sup-
plemented with subcutaneous opioid remain the mainstay
of postoperative pain relief.31 In our study, these “basic
analgesics” induce a light, nonsignificant morphine-spar-
ing effect, but the range of morphine consumption is
extremely variable. This finding is in line with previous
surveys.24 In addition, Egberg et al.32 showed that the
postoperative requirement for morphine could be re-
duced by one half by providing preoperative information
about severity and duration of postoperative pain and
twice daily postoperative visits and support. This phenom-
enon of “opioid sparing” by the nonpharmacologic
method of providing psychological support and informa-
tion to patients must be integrated. Although comparison
with other studies is difficult, these results compare favor-
ably with published data on opioid analgesia.
Regional techniques were restricted to selected patients
not included in the present survey. These patients were
managed in the ICU, where staff and equipment ensure
appropriate monitoring and management of complica-
tions. In the present study, we focused only on patients
managed in surgical wards. We are convinced that re-
gional techniques are ideal after most major surgical
procedures and that their use should be extended to the
general wards after development of appropriate facilities.
Formal protocols, with monitoring of sedation level, res-
piration, and blood pressure, permit systematic and epi-
dural analgesic drugs to be given safely in the general
wards.15,33
The principal limitation related to the study design is
that only rest pain was assessed. Adequate control of this
kind of pain is easier than movement pain.9 Further
studies will now focus on pain during mobilization using
the same methodologic approach. Moreover, the impact
of improved postoperative analgesia in terms of overall
surgical outcome remains to be determined.
The present study validates the benefits of a formal
nurse-based APS, using continuous monitoring of rest
pain intensity and analgesic consumption in the postop-
erative period. Results not only support previous research
findings but also offer outcome-based tools to evaluate
current practices as compared with desired outcomes.
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